Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is -5415.19%.
Reported quarterly operating margin; no daily interpolation.
Limited quarterly history available
Operating Margin needs at least three reported quarters before a meaningful chart is shown.
OPERATING MARGIN
-5415.19%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Odyssey Therapeutics, Inc.
Market Cap
$870.81M
Operating Margin
-5415.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.03M
Operating Margin
-8.31%
TTM Avg
-16.09%
3Y Avg
-30.50%
5Y Avg
-38.64%
Market Cap
$857.16M
Operating Margin
-30.67%
TTM Avg
-52.06%
3Y Avg
-18.41%
5Y Avg
7.25%
Market Cap
$884.97M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
Market Cap
$855.38M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$887.50M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$887.99M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$853.13M
Operating Margin
42.63%
TTM Avg
28.06%
3Y Avg
-1.90%
5Y Avg
-7.11%
Market Cap
$852.35M
Operating Margin
-174.65%
TTM Avg
-105.11%
3Y Avg
-66.40%
5Y Avg
-66.40%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Odyssey Therapeutics, Inc. (ODTX) | $870.81M | -5415.19% | N/A | N/A | N/A |
| SI-BONE, Inc. (SIBN)vs › | $867.03M | -8.31% | -16.09% | -30.50% | -38.64% |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | -30.67% | -52.06% | -18.41% | 7.25% |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | -192.08% | -714.41% | -506.77% | -588.71% |
| Alumis Inc. (ALMS)vs › | $855.38M | -1776.32% | -888.16% | -444.08% | -444.08% |
| Bioventus Inc. (BVS)vs › | $887.50M | 10.63% | 4.11% | -10.10% | -5.16% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 42.63% | 28.06% | -1.90% | -7.11% |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | -174.65% | -105.11% | -66.40% | -66.40% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | -348.46% | -328.22% | -265.67% | -226.03% |
Gross Margin
100.0%
Operating Margin
-5415.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
